Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Vertex (VRTX) to Begin Pivotal Study on Kidney Candidate
12:28pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Vertex's (VRTX) pivotal phase III study on VX-147 targeting a broad patient population with proteinuric kidney disease mediated by two mutations in the APOL1 gene (AMKD) is expected to begin later thi
Missed Out on Moderna? My Best Biotech Stock to Buy and Hold
10:30am, Wednesday, 23'rd Mar 2022 The Motley Fool
This company is working with Moderna on an exciting program.
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
09:50pm, Friday, 18'th Mar 2022 Zacks Investment Research
CRISPR Therapeutics AG (CRSP) closed at $67.89 in the latest trading session, marking a +0.64% move from the prior day.
3 Cathie Wood Stocks to Buy and Hold for 10 Years
11:16am, Friday, 18'th Mar 2022 The Motley Fool
Check out these high-potential growth stocks while they're still affordable.
3 Cathie Wood Stocks to Buy and Hold for 10 Years
07:16am, Friday, 18'th Mar 2022
Check out these high-potential growth stocks while they're still affordable.
CRISPR Therapeutics AG (CRSP) Up 5.8% Since Last Earnings Report: Can It Continue?
03:30pm, Thursday, 17'th Mar 2022 Zacks Investment Research
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CRISPR Therapeutics AG (CRSP) Up 5.8% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 17'th Mar 2022
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock?
Crispr Therapeutics AG's (CRSP) CEO Sam Kulkarni Presents at Barclays Global Healthcare Conference (Transcript)
12:17pm, Thursday, 17'th Mar 2022
Crispr Therapeutics AG's (CRSP) CEO Sam Kulkarni Presents at Barclays Global Healthcare Conference (Transcript)
BeiGene, Ltd. (BGNE) Soars 25.1%: Is Further Upside Left in the Stock?
09:38am, Thursday, 17'th Mar 2022 Zacks Investment Research
BeiGene, Ltd. (BGNE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa
Who Benefits From Amazon's Stock Split?
04:27pm, Wednesday, 16'th Mar 2022 The Motley Fool
Plus Tess Vigeland, host of The Wall Street Journal podcast "As We Work," joins us for a chat.
Is CRISPR Therapeutics Stock a Buy Now?
02:37pm, Wednesday, 16'th Mar 2022 The Motley Fool
It's been a tough past 12 months for this gene-editing specialist.
Is CRISPR Therapeutics Stock a Buy Now?
02:37pm, Wednesday, 16'th Mar 2022 The Motley Fool
It''s been a tough past 12 months for this gene-editing specialist.
Here''s How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
02:13pm, Wednesday, 16'th Mar 2022 Benzinga
CRISPR Therapeutics (NASDAQ: CRSP ) has outperformed the market over the past 5 years by 12.95% on an annualized basis. Buying $1,000 In CRSP: 5 years ago, an investor could have purchased 47.08 shares of CRISPR Therapeutics at the time with $1,000. This investment in CRSP … Full story available on Benzinga.com
CRISPR Therapeutics AG (NASDAQ: CRSP) Is A Buzzing Hot Stock
01:30pm, Wednesday, 16'th Mar 2022 Stocks Register
CRISPR Therapeutics AG (NASDAQ:CRSP) traded at $60.04 at close of the session on Tuesday, 03/15/22, made an upward move of 3.41% on its previous day’s price. Looking at the stock we see that its previous close was $58.06 and the beta (5Y monthly) reads 2.08 with the day’s price range being $57.78 – $60.77. The … CRISPR Therapeutics AG (NASDAQ: CRSP) Is A Buzzing Hot Stock Read More »
Is CRISPR Therapeutics Stock a Buy Now?
10:37am, Wednesday, 16'th Mar 2022
It's been a tough past 12 months for this gene-editing specialist.
